PPP2R5C
PPP2R5C (Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
Overview
The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localisation of the catalytic enzyme to a particular subcellular compartment. The PP2A-PPP2R5C holoenzyme may specifically dephosphorylate and activate TP53 and play a role in DNA damage-induced inhibition of cell proliferation. PP2A-PPP2R5C may also regulate the ERK signalling pathway through ERK dephosphorylation.
Open Targets scores its association with cancer at 0.59 (direct and indirect evidence; datatypes affected pathway 0.89, literature 0.82, genetic association 0.00, somatic mutation 0.23, animal model 0.32). In OnCo, 1 product record names it (Cologuard Plus).
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · PPP2R5C (Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
- 1 · What it is
PPP2R5C (Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform) is a gene. In the public catalogues the evidence so far is association rather than a proven role.
- 2 · What goes wrong in cancer
The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localisation of the catalytic enzyme to a particular subcellular compartment.
- 3 · How drugs use it
No product in this corpus aims at PPP2R5C yet. Drugs bind the molecule precisely: to switch it off, flag the cell for the immune system, or deliver a payload.
External identifiers
Sources: HGNC HGNC:9311 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q13362 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000078304 (association with cancer (MONDO_0004992) 0.59; (GraphQL API, CC0))
Biology
The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localisation of the catalytic enzyme to a particular subcellular compartment. The PP2A-PPP2R5C holoenzyme may specifically dephosphorylate and activate TP53 and play a role in DNA damage-induced inhibition of cell proliferation. PP2A-PPP2R5C may also regulate the ERK signalling pathway through ERK dephosphorylation. Location: Nucleus; Chromosome, centromere (UniProt). Locus 14q32.31 (HGNC).
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: none stated by the sources. Evidence tier "association-only" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"PPP2R5C" OR ABSTRACT:"PPP2R5C" OR TITLE:"protein phosphatase 2 regulatory subunit B'gamma" OR ABSTRACT:"protein phosphatase 2 regulatory subunit B'gamma" OR TITLE:"Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform" OR ABSTRACT:"Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform" OR TITLE:"B56G" OR ABSTRACT:"B56G" OR TITLE:"PR61G" OR ABSTRACT:"PR61G" OR TITLE:"B56gamma" OR ABSTRACT:"B56gamma") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PPP2R5C, not a curated reading list.